{"url_path":"/sec/tnxp/8-k/2026-07-21/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-21","source_url":"https://www.sec.gov/Archives/edgar/data/1430306/0001493152-26-034079-index.html","accession_number":"0001493152-26-034079","cik":"0001430306","ticker":"TNXP","issuer_name":"Tonix Pharmaceuticals Holding Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1430306/0001493152-26-034079-index.html","primary_entity_key":"0001430306","primary_entity_name":"Tonix Pharmaceuticals Holding Corp."},"word_count":101,"has_tables":true,"body_markdown":"**Item\n5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of\nCertain Officers.**\n\n** **\n\nOn\nJuly 20, 2026, Dr. Gregory M. Sullivan informed Tonix Pharmaceuticals Holding Corp. (the “Company”) that he will retire from\nhis role as Chief Medical Officer of the Company, effective August 20, 2026.\n\n \n\n \n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant\nto the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the\nundersigned thereunto duly authorized.\n\n \n\n \n**TONIX\nPHARMACEUTICALS HOLDING CORP.**\n\n \n \n\nDate:\nJuly 21, 2026\nBy:\n\n*/s/\nBradley Saenger*\n\n \n \nBradley\nSaenger\n\n \n \nChief\nFinancial Officer"}